Legal weed looks good on paper. Dispensaries that feel like Apple stores. Influencer product drops. Celebrities launching “wellness” brands from Manhattan to Malibu. But peel back the shiny packaging and the question hits hard: Who’s really cashing in on cannabis, and who’s still paying the price?

That’s the heartbeat of Kiss My Grass, a short documentary that refuses to let the industry off the hook. Written by Roy Wood, Jr., directed by Mary Pryor, Mara Whitehead, co-directed by Tirsa Hackshaw and narrated by actor and activist Rosario Dawson, the film doesn’t waste time glamorizing the Green Rush. Instead, it zooms in on the people of color, particularly Black women, who’ve had to fight their way into a market that was never built for them.

In less than 20 minutes, Kiss My Grass manages to hit every nerve with candid interviews that strip the false promises of legalization down to its bones. It’s in these raw, personal stories from trailblazers including Kim James, Matha Figaro, Jessica Jackson and Coss Martewhere the documentary hits hardest. Watching them, you’re forced to confront a painful reality: Legalization was sold as a new beginning, but the same old systems keep showing up with new branding.

After watching the film, I had a lot of questions about what it actually takes to make progress in such a complicated system and had the opportunity to ask some of the featured individuals about what’s changed, what hasn’t and what needs to happen.

“True equity requires structural repair,” says Jackson, director of social equity for Minnesota’s Office of Cannabis Management. “That means reinvestment into harmed communities; expungement and record repair; rules that prevent hidden ownership and monopolization; workforce protections; and readiness tools like technical assistance—all interventions Minnesota provided from the start in Chapter 342 legislation.”

While the cannabis industry is expected to hit $45 billion in 2025, equity programs meant to level the field often feel more like public relations stunts than progress in some states. The numbers from around the country tell the story: Only 0.35 percent of venture capital reaches Black women founders. Black people are still 3.7 times more likely to be arrested for possession.

“Access to capital, affordable real estate, and navigating complex regulations are major barriers,” says James, who leads Detroit’s Office of Cannabis Management. “Many equity programs don’t address the systemic economic disadvantages experienced by people who come from communities disproportionately impacted by the War on Drugs.”

It’s just even more of a reminder that legal doesn’t mean fair for the communities that got felonies instead of spots on the Forbes list for selling cannabis.

As Coss Marte, founder of fitness empire CONBODY, puts it, “If you’re making millions off cannabis, you have a moral obligation to invest in the communities that paid the price for prohibition,” he says. “That means jobs, ownership and capital—not charity optics. Repair starts when money, mentorship and opportunity flow directly to the people most impacted.”

Still, this isn’t a film that wallows in defeat. It’s about persistence. You feel the exhaustion, but also the refusal to give up. You see the discouragement, but also a spark of hope for the future. If there’s one message this film makes clear it’s that equity won’t grow on its own, but it can take root if we tend to it.

For Figaro, the founder behind ButACake and CannPowerment, the future of cannabis isn’t just about who gets in the door now, but what the next generation of women of color will inherit. When asked what needs to change to make that possible, she didn’t hold back. “My hope is that future generations inherit thriving cannabis businesses and the tools to bring underrepresented voices to market,” she says. “But to get there, we must dismantle the small-minded and misinformed policymakers writing rules they’ll never be forced to follow.”

After making its debut at the Tribeca Film Festival this past summer, Kiss My Grass is set for a wider digital release at a later date. Whether you work in cannabis or just care about justice, it’s essential viewing about what happens when an industry sells progress but delivers privilege. It leaves you moved. It leaves you mad. And, just maybe, that’s the point.

The post ‘Kiss My Grass’ Speaks Truth appeared first on Cannabis Now.

From the block to the boardroom, hip hop and cannabis share a legacy of creativity, resistance, and resilience. As the legal marijuana industry grows, the culture that allowed it to be built must not be left behind.

Vic Mensa: How to keep cannabis culture alive in the boardroom is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

If you are a student of space history or tracked the space industry before billionaires and venture capital changed it forever, you probably know the name Rocketdyne.

A half-century ago, Rocketdyne manufactured almost all of the large liquid-fueled rocket engines in the United States. The Saturn V rocket that boosted astronauts toward the Moon relied on powerful engines developed by Rocketdyne, as did the Space Shuttle, the Atlas, Thor, and Delta rockets, and the US military's earliest ballistic missiles.

Rocketdyne's dominance began to erode after the end of the Cold War. The company started in 1955 as a division of North American Aviation, then became part of Rockwell International until Boeing acquired Rockwell's aerospace division in 1996. Rocketdyne continually designed and tested large new rocket engines from the 1950s through the 1980s. Since then, Rocketdyne has developed and qualified just one large engine design from scratch—the RS-68—and it retired from service in 2024.

Read full article

Comments

© NASA

A Kirkland, Wash.-based tech company is suing its New York-based acquisition advisor, alleging it was pushed into a $5.2 million acquisition that was supposed to generate $1 million annually but has instead required ongoing cash infusions just to stay afloat.

The lawsuit, filed on behalf of SmarTek21, a longtime technology consulting services firm, accuses TGP GP Management of “egregiously defective due diligence” in its May 2025 acquisition of IT Avalon, another U.S.-based tech consulting company.

According to the complaint, Tortuga Growth Partners, a New York-based private equity firm, acquired a minority stake in SmarTek21 in 2024. Its affiliate, TGP GP Management, a management and acquisition advisory firm, entered into an agreement to advise SmarTek21 on acquisitions and related matters.

TGP responded in a statement: “TGP strongly disputes the allegations in this complaint and stands by the comprehensive due diligence process conducted for the IT Avalon acquisition.”

The lawsuit was filed Dec. 18 in King County Superior Court in Seattle by Totem Lake Investments II, the majority owner of SmarTek21. Totem Lake Investments is led by SmarTek21 CEO Alkarim Lalji. The suit seeks at least $6 million in damages, plus punitive damages and other relief.

According to the complaint, TGP almost immediately began pressuring SmarTek21 to acquire IT Avalon, as a complementary business that would augment SmarTek21’s existing model and diversify its customer base. The suit says TGP represented that IT Avalon would generate at least $1 million annually in free cash flow, before other benefits from the combination.

The complaint alleges that TGP’s principal Ashray Prasad dismissed concerns raised by SmarTek21 executives about IT Avalon’s deteriorating finances in the days before closing. According to the suit, Prasad repeatedly called Lalji urging him to close the deal — placing many of these calls while Lalji was undergoing treatment for a serious medical condition.

The lawsuit alleges TGP pursued the IT Avalon acquisition out of “enthusiasm for transaction fees, publicity, and the appearance of quick deal-making.”

According to the suit, IT Avalon’s revenue had been declining since 2022, and its operating income had dropped significantly, while its vendor relationships deteriorated.

TGP structured the deal so that any working capital shortfall would be offset against future earnout payments to IT Avalon’s sellers. But that proved worthless, the suit alleges, because IT Avalon had almost no chance of hitting the revenue targets that would trigger those payments.

In its statement, TGP disputed these claims.

“IT Avalon is a strong technology business with valuable client relationships,” it said. “The combined entity now benefits from an expanded client base, talented personnel, and a robust pipeline of opportunities. We intend to vigorously defend against these baseless claims.”

The dispute illustrates the complicated nature of private equity-led technology roll-up strategies, in which smaller companies are combined to create larger platforms.

The acquisition of IT Avalon in May was the second in six months for SmarTek21, following its earlier combination with Retro Rabbit, a South Africa-based product design firm, according to a press release by Tortuga Growth Partners announcing the IT Avalon deal at the time.

“We are building a category-defining platform,” said TGP’s Prasad, who is also a member of SmarTek21’s board of managers, in the press release. He added that the completion of the second acquisition over that time frame reflected “the momentum behind SmarTek21’s growth.”

According to the company’s public materials, SmarTek21 provides product engineering and enterprise software services to Fortune 250 clients in industries including financial services, healthcare, and telecom. It says it has more than 650 associates across the U.S., India, and South Africa.

IT Avalon, founded in 2012, provides technology consulting services to clients in financial services, healthcare, gaming, and hospitality. The May press release announcing the deal described the company as having a 95% client retention rate.

Lalji and SmarTek21 did not respond to requests for comment. See the full complaint below.

SmarTek21 v. TGP Management by GeekWire

Rhode Island’s top cannabis regulator is stepping down a day after establishing the timeline for awarding the state’s 24 new cannabis retail licenses.

Rhode Island cannabis chief exits as new retail permit timeline announced is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

From building brands to advocating for social equity, women are breaking barriers, driving innovation and championing equity in the cannabis industry.

MJBizCon highlights women driving diversity in cannabis is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Today, “equity” is a watchword in the cannabis legalization movement, as state and local governments try to craft models for an adult-use market designed to correct the social harms of prohibition and the War on Drugs. But this public consciousness is due to the work of many who pushed the issue long before doing so was entirely socially acceptable.

Sister Somayah Kambui, a veteran Black Panther turned cannabis advocate, was one of those who brought issues of racial justice to the forefront of the cannabis movement. And before her untimely death, she won a groundbreaking “jury nullification” victory, upholding her right to provide cannabis to treat sickle-cell anemia.

Sister Somayah, as she was ubiquitously known (she was born Renee Moore), used cannabis to treat sickle-cell anemia, under the terms of California’s Proposition 215 medical marijuana measure after its passage in 1996. But her vocal advocacy made her a target of the authorities — resulting in her unprecedented legal victory. 

Sickle-cell anemia is a genetic blood anomaly that occurs in one in every 70,000 Americans, particularly those of African descent. It can cause debilitating pain, fatigue and swelling of the hands and feet. It took Kambui a while to figure out that cannabis was the most effective treatment for her.

Kambui was a veteran of the U.S. Air Force, where she served several years during the Vietnam era. At VA and public hospitals, she was given morphine for her pain from the disease. 

“I couldn’t do anything on the morph,” she told High Times reporter Peter Gorman. “And neither can a million other people. That’s why you see so many middle aged and older black folk sitting on stoops looking like junkies. They are junkies. They’re U.S. government junkies.”

After finding that cannabis helped, and after the passage of Prop 215, she founded the Crescent Alliance Self Help for Sickle Cell collective, or “buyers’ club.” With a doctor’s recommendation, she began cultivating in her South Los Angeles backyard.

But the police raided her garden in October 2001 and confiscated, by their estimate, 200 pounds of cannabis plants. 

The LAPD brought in a helicopter for the raid, menacing the block of single-family homes.

“I was sitting having a cup of coffee with a little hemp oil when they broke down the door,” Kambui told the Los Angeles Times. “I said, ‘I’m legal, I have a doctor’s note and I’m compliant with the law.'”

She said the officers told her she had too much for her personal use. “I said ‘OK, why don’t you take what you think I don’t need and leave me the rest?'” she recalled to the LA Times. “They took it all.” 

She also disputed the police estimate of the haul. “That is 200 pounds wet, with dirt and stalks,” she said.

Kambui was arrested, spent 60 days in jail and was charged with multiple felonies including cultivation, sale and shipping marijuana out of state. Worse still, she was facing a life prison term under California’s “Three Strikes” law. Her two prior convictions, involving illegal firearms possession and explosives, stemmed from her work with the Black Panthers in the early 1970s. During her time as a legendary Panther, she was known as “Peaches,” and was a leader of the Southern California Chapter of the Black Panther Party, alongside Geronimo Pratt.

When she went before the judge at Los Angeles County Court in January 2002, Kambui said the cannabis was not for her use alone, but was to be shared with some dozen sickle-cell sufferers in her club. “They’re all mine,” she said, taking full responsibility for all the uprooted plants. She also admitted shipping to sufferers who were too far away to come see her. 

And she asserted that her advocacy had made her a target, noting that she’d been similarly raided in 1998 — although the charges were dropped after she spent two weeks in jail.  

Making a medical necessity defense, Kambui spoke to the court of the long centuries of medicinal cannabis use in African traditional healing. Using her own idiosyncratic lingo, she referred to the African continent as “Nigretia,” and to her cannabis as “Nigretian Kif.”  

The trial ended in an outcome that The Leaf Online website hailed as a “jury revolt or jury nullification,” in which a defendant is acquitted on moral or ethical grounds, in spite of uncontested evidence that she or he acted as charged. On March 18, 2002, Sister Somayah Kambui was found “not guilty” of all charges.

In addition to being a rare victory for the doctrine of nullification, Kambui’s legal battle also anticipated a change in California law. It was the following year that the “medical marijuana collective defense” was enshrined in the Medical Marijuana Program Act, the notorious Senate Bill 420. 

Pushing Racial Justice in the Cannabis Community 

By the time of her court case, Kambui was already a leading figure in Southern California’s cannabis activist scene. She was the key mover behind the first Los Angeles Global Marijuana March in 1999, and all the subsequent ones until her death. And she was particularly aggressive in calling out the cannabis community one what she saw as its internal racism — for instance, in failing to emphasize sickle-cell anemia in medical marijuana advocacy, and failing to make the link between prohibition and militarized policing of black and brown communities.

But she bridged a cultural divide in 1997, when she teamed up with B.E. Smith, a brazen and police-defying cannabis grower of white redneck roots in the backwoods of Northern California’s Trinity Alps. Smith became “designated caregiver” for Kambui, among a handful of other medical users around the state. Alas, she never got to use B.E.’s bud, as his cultivation site was raided by federal agents that harvest season—resulting in his own landmark legal battle. Smith died earlier this year.

Unfortunately, Kambui’s run-ins with the law were not over after her court victory. In October 2003, her garden was again raided — this time by the DEA. A dozen plants were uprooted, although no charges were filed. 

California NORML coordinator Dale Gieringer decried the raid as a “mean-spirited, gratuitous attack on a seriously ill woman who has been judged guiltless by her peers under California law. Like other victims of DEA’s medical marijuana raids, Somayah was targeted because she was a vocal, legal patient activist who was a thorn in the side of the law enforcement establishment.” 

Like many front-line activists who put a commitment to community ahead of personal gain, Kambui received little material reward for her efforts. When she died on Thanksgiving 2008, at the age of 57, the website Time4Hemp wrote that economic hard times likely contributed to her demise: “Many close to her believe she died of a broken heart based on lack of financial support. All those dispensaries in Los Angeles and not one would help her save her home from foreclosure.” 

Twelve years after her passing, Sister Somayah Kambui reminds us of the need to preserve the memory of those who sacrificed for such freedom and consciousness as we have now achieved. And more poignantly, of the need to honor and support our freedom fighters while they still walk among us. 

TELL US, what did you learn from Sister Somayah?

The post Sister Somayah Kambui: An Early Visionary of Cannabis Equity appeared first on Cannabis Now.

40 Tons, the multi-state, social impact cannabis brand dedicated to justice and equity, is bringing its groundbreaking Justice Row activation to NECANN Boston 2025, taking place March 21-22 at the Hynes Convention Center in Boston, Massachusetts. Justice Row ensures that justice-impacted entrepreneurs—those who have paid the highest price for cannabis while others profit—are no longer […]

The post 40 Tons Brings “Justice Row” to NECANN Boston, Paving the Way for Justice-Impacted Entrepreneurs  appeared first on The Weed Blog.

I have been a cannabis advocate since before I began my journey in the cannabis industry, and I can still tie every hat I wear (and have ever worn) in the industry back to advocacy. It is essential that cannabis industry professionals and cannabis consumers are aware of the dark history of the war on […]

The post The War on Drugs and Its Repercussions: A New Era for Cannabis Justice appeared first on The Weed Blog.

The Minority Cannabis Business Association (MCBA) is currently in the midst of its highly anticipated Equity Workshop Tour 2024. This tour aims to empower minority entrepreneurs and advocates within the cannabis industry through a series of workshops designed to address the unique challenges they face. MCBA, a leading national nonprofit organization, continues its mission to […]

The post The Minority Cannabis Business Association’s Equity Workshop Tour 2024 Continues to Empower Communities and Foster Inclusion appeared first on The Weed Blog.

The Illinois Cannabis Regulation Oversight Office (CROO) announced on Feb. 7 that it launched its Cannabis Disparity and Availability Study, which tasks a contract group to find examples of discrimination within the local cannabis industry.

According to CROO, the study “will collect and analyze data and report on whether discrimination exists in the Illinois cannabis industry,” CROO states on its website. “If there is a finding that discrimination exists, the Disparity Study will evaluate the impact of the discrimination on the State and its residents regarding entering and participating in the State’s cannabis industry. The Disparity Study will include recommendations for reducing or eliminating any identified barriers to entry.“

The study will examine laws and court cases that involve cannabis and cannabis and disparity studies, conduct interviews and create focus groups for public input, and compile data in relation to the state’s cannabis application process and business information.

A final report is required to be sent to the General Assembly and governor within 12 months, including any “potential remedies” to amend current cannabis regulation. “This effort is a vital assessment of the state’s cannabis social equity licensing system,” said Acting CROO Officer Erin Johnson. “We look forward to seeing a final report that truly incorporates the voices of Illinois social equity applicants and our new cannabis businesses.”

This comes nearly one year since the state issued a request to find someone to conduct the Disparity Study in Feb. 2022. This led to the hiring of the Nerevu Group, which is a minority- and women-owned contractor group based throughout Illinois, as well as some out-of-state locations.

“Along with our partners, Nerevu is honored to support CROO, IDFPR and IDOA in building an even more inclusive and equitable cannabis industry,” said Nerevu Group Founder and President Reuben Cummings. “This study is essential in identifying potential disparities and suitable remedies. We are excited to initiate this project and look forward to connecting with the greater cannabis community.”

Legal adult-use cannabis sales began in 2020, and in July 2022, Gov. J.B. Pritzker announced that 149 condition state licenses would be issued and available for social equity applicants. “Illinois is leading the way in addressing the War on Drugs as no state has before, and dispensary ownership that reflects our state’s diversity is a product of that commitment,” said Pritzker. “These licenses represent a significant step toward accountability for the decades of injustice preceding cannabis legalization. Illinois will continue to deliver on the promises of putting equity at the forefront of this process.”

Just a few months later, two of the state’s first social equity cannabis dispensaries, Ivy Hall Damen and Green Rose Dispensary, opened in November 2022 in Chicago.

According to Nigel Dandridge, the co-founder of Ivy Hall Damen, it’s taken a long time for his business to open up. “We’ve been working to get a seat at the table for a while now, and we’re finally able to do that,” said Dandridge. “When this industry first opened up, we didn’t see anyone in our community benefiting, or even being able to participate. So it was kind of hypocritical. I think it’s important that we can show you what we’re doing. We want everyone to benefit. Our staff’s been working hard, and we’re just excited to share it with everyone.”

Falling in line with other states in the U.S., Illinois Rep. La Shawn Ford recently introduced House Bill 1 to legalize psychedelics in January. Ford’s bill would allow residents 18 years and older to seek out supervised psychedelic therapy. “I want to be clear that this is a health measure. My proposal does not allow retail sales of psilocybin outside of a regulated therapeutic setting and ensures that medicines purchased for therapeutic use at a service center must be used under medical supervision, and cannot be taken home,” Ford said. “Only licensed facilitators will be allowed to provide treatment at closely regulated and licensed healing centers, approved health care facilities, in hospice, or at a pre-approved patient residence.”

The post Illinois Announces Launch of Cannabis Disparity Study appeared first on High Times.

Democratic lawmakers in Delaware last week performed what has become an annual legislative ritual by introducing measures that would legalize recreational marijuana.

And, as per recent tradition, their biggest obstacle remains the most senior member of their own state party. 

The Delaware News Journal reports that members of the state House of Representatives introduced a pair of bills on Friday “to legalize and create a recreational marijuana industry in Delaware, setting up a likely fight within the Democratic Party this legislative session.” 

The anticipated intra-party feud centers around Democratic Gov. John Carney, who has long been opposed to marijuana legalization and has stymied efforts by Democrats in the legislature to end the prohibition on pot. 

Last year, Carney vetoed a bill that would have legalized recreational pot in the state. 

Despite holding a majority in each chamber of the state General Assembly, Democratic lawmakers were unable to override Carney’s veto.

“[The legalization bill] would, among other things, remove all penalties for possession by a person 21 years of age or older of one ounce or less of marijuana and ensure that there are no criminal or civil penalties for transfers without remuneration of one ounce or less of marijuana between persons who are 21 years of age or older,” Carney said in a statement following his veto.

“I recognize the positive effect marijuana can have for people with certain health conditions, and for that reason, I continue to support the medical marijuana industry in Delaware,” he continued. “I supported decriminalization of marijuana because I agree that individuals should not be imprisoned solely for the possession and private use of a small amount of marijuana—and today, thanks to Delaware’s decriminalization law, they are not.”

“That said, I do not believe that promoting or expanding the use of recreational marijuana is in the best interests of the state of Delaware, especially our young people,” Carney added. “Questions about the long-term health and economic impacts of recreational marijuana use, as well as serious law enforcement concerns, remain unresolved.”

Democrats who are backing the two bills introduced in the state House last week are hopeful that Carney will eventually come around.

“My hope is that with continued open dialogue with the governor’s office, that will help alleviate a veto,” Democratic state House Rep. Ed Osienski, one of the sponsors of the legislation, told the Delaware News Journal. “I have more support from my members … for a veto override, but I’m hoping it doesn’t come to that.”

According to the outlet, a “Carney spokeswoman said Friday that the governor’s views on marijuana have not changed.”

According to the Delaware News Journal, the bill dedicated to removing all penalties for possession would “require a simple majority or 21 votes.”

The other bill “would create a framework to regulate the growth, sale and possession of weed,” essentially treating pot like alcohol, and would require “a three-fifths vote because it deals with revenue and taxation,” the Delaware News Journal reports.

The measures also include social equity provisions aimed at enhancing opportunities in the new marijuana industry to individuals from communities who have been historically targeted by anti-drug policies.

The News Journal has more details on the two proposals:

“Delawareans would buy marijuana from a licensed retail marijuana store. The bill would allow for up to 30 retail licenses to be distributed within 16 months of the legislation going into effect. The process will be competitive, with prospective retailers being rewarded for providing good salaries and benefits and hiring a diverse workforce.”

The post Delaware Lawmakers Renew Effort To Legalize Pot appeared first on High Times.